SEC Form 4 · accession 0001209191-17-054169
PURE BIOSCIENCE, INC. · PURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Tom Y Lee
Director
Period of report
Sep 25, 2017
Accepted (ET)
Sep 27, 2017 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006028
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 25, 2017 | M | 320,000 | $0.60 | A | 4,154,452 | D | |
| Common Stock | Sep 25, 2017 | M | 166,666 | $0.40 | A | 717,665 | I | By Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $0.75 | Sep 25, 2017 | D | 320,000 | D | Aug 29, 2014 | Aug 29, 2019 | Common Stock | 320,000 | 0 | D |
| WarrantF1 | $0.60 | Sep 25, 2017 | A | 320,000 | A | Aug 29, 2014 | Sep 25, 2017 | Common Stock | 320,000 | 320,000 | D |
| WarrantF2 | $0.60 | Sep 25, 2017 | M | 320,000 | D | Aug 29, 2014 | Sep 25, 2017 | Common Stock | 320,000 | 0 | D |
| WarrantF3 | $0.45 | Sep 25, 2017 | D | 166,666 | D | Nov 23, 2015 | Nov 23, 2020 | Common Stock | 166,666 | 0 | I |
| WarrantF3 | $0.40 | Sep 25, 2017 | A | 166,666 | A | Nov 23, 2015 | Sep 25, 2017 | Common Stock | 166,666 | 166,666 | I |
| WarrantF4 | $0.40 | Sep 25, 2017 | M | 166,666 | D | Nov 23, 2015 | Sep 25, 2017 | Common Stock | 166,666 | 0 | I |
Explanation of responses
- F1On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.
- F2In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.
- F3On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.
- F4In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised her 2015 Warrant in full and in cash on September 25, 2017.